✦ LIBER ✦

Primary Intermittent Androgen Deprivation As Initial Therapy for Men with Newly Diagnosed Prostate Cancer

✍ Scribed by Mark C. Scholz; Richard Y. Lam; Stephen B. Strum; Dean J. LaBarba; Lauren K. Becker; Patricia Chang; Nojan Farhoumand; Robert I. Jennrich

Book ID: 113538991
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 230 KB
Volume: 9
Category: Article
ISSN: 1558-7673
DOI: 10.1016/j.clgc.2011.07.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Contemporary patterns of androgen depriv

Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer

✍ Maxwell V Meng; Gary D Grossfeld; Natalia Sadetsky; Shilpa S Mehta; Deborah P Lu 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Primary androgen deprivation (AD) Follow

Primary androgen deprivation (AD) Followed by active surveillance (AS) for newly diagnosed prostate cancer (PC): A retrospective study

✍ Mark C. Scholz; Meg K. Groom; Andrew J. Kaddis; Stephen B. Strum; Robert I. Jenn 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

351 INTERMITTENT ANDROGEN DEPRIVATION AS

351 INTERMITTENT ANDROGEN DEPRIVATION AS SECONDARY THERAPY FOR BIOCHEMICAL RECURRENCE OF LOCALIZED PROSTATE CANCER

✍ Sanchez-Salas, Rafael; Prapotnich, Dominique; Secin, Fernando; Favaretto, Ricard 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 166 KB

762 FRAX® ASSESSMENT OF MEN TREATED WITH

762 FRAX® ASSESSMENT OF MEN TREATED WITH ANDROGEN DEPRIVATION THERAPY FOR PROSTATE CANCER

✍ Turo, Rafal; Cross, William 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB

Avoiding Androgen Deprivation Therapy in

Avoiding Androgen Deprivation Therapy in Men With High-risk Prostate Cancer: The Role of Radical Prostatectomy as Initial Treatment

✍ Ranko Miocinovic; Ryan K. Berglund; Andrew J. Stephenson; J. Stephen Jones; Amr 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 472 KB

Causes of death in men undergoing androg

Causes of death in men undergoing androgen suppression therapy for newly diagnosed localized or recurrent prostate cancer

✍ Anthony V. D'Amico; Ming-Hui Chen; Andrew A. Renshaw; Marian Loffredo; Philip W. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Abstract ## BACKGROUND. The authors estimated and characterized mortality after androgen suppression therapy (AST) use in men with newly diagnosed localized and recurrent prostate cancer. ## METHODS. The study cohorts comprised 102 men who were randomized to radiation therapy (RT) and AST and